Used to be a great company to work for, its now ok, but not great - Recensione dipendente - Principal Scientist presso AstraZeneca

4,0
24 giu 2013
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Company is in flux and reorg, so some opportunities will arise for those that are mobil

Svantaggi

company in flux and reorg, and not clear if new strategy will deliver.

Esplora altre recensioni su AstraZeneca

5,0
17 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

great place to work and develop!

Svantaggi

could maybe have more transparency

1,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The page is friendly to make an application.

Svantaggi

As an experienced healthcare analytics and commercial leader, I applied to 104 U.S.-based positions at AstraZeneca between 2025 and 2026 that closely matched my background. Despite receiving interviews from peer organizations, I did not receive a single recruiter interaction. I fully understand the competitiveness of hiring, but such a complete lack of engagement raises questions about potential overreliance on AI screening or unintended bias.

Vedi recensioni per: Utile|Valutazione|Data|Tutto